Skip to content
Melanoma Immune Oncology Research Group
Melanoma Immune Oncology Research Group

Melanoma Immune Oncology Research Group

Improving Immunotherapy for Metastatic Melanoma

  • Home
  • About Us
  • The Group and Contributors
  • Projects
  • Publications
  • Opportunities
  • Contact Us
  • Sponsors

Author: utuwebmaster

Posted on September 29, 2020December 16, 2020

Welcome to MIORG, hosted by MediCity.

#ROGERLAB

MIORGFollow

MIORG
Roger84058338MIORG@Roger84058338·
11 Mar

https://www.utu.fi/fi/ajankohtaista/uutinen/suomen-akatemia-myonsi-turun-yliopistolle-lahes-kolme-miljoonaa-euroa?fbclid=IwAR1w9p-Z0k31w9b8WxrUR3tx2URD-Zep6ZIpk6-E2UK4rpQGrhObsZSowEE

Reply on Twitter 1369989688405147651Retweet on Twitter 1369989688405147651Like on Twitter 1369989688405147651Twitter 1369989688405147651
Roger84058338MIORG@Roger84058338·
26 Jan

https://www.youtube.com/watch?v=_VhcZTGv0CU

Reply on Twitter 1354054504182853632Retweet on Twitter 1354054504182853632Like on Twitter 1354054504182853632Twitter 1354054504182853632
Roger84058338MIORG@Roger84058338·
26 Oct

A new study from researchers in Finland and the United Kingdom reveals that tumours lacking a protein called BAP1 have an ineffective immune reaction against cancer, thus rendering immunotherapies ineffectual, particularly in uveal melanomas (UM).
https://bit.ly/3juGzwb

Reply on Twitter 1320630653847744514Retweet on Twitter 13206306538477445142Like on Twitter 1320630653847744514Twitter 1320630653847744514
Load More...
Proudly powered by WordPress